Bayer Rep Joins Board Of Soil Amendment Company

IMG_20140529_125210-e1401471708138

The President and CEO of Bayer CropScience is now on the board of directors of a Montreal based agriculture biotech company.

Jim Blome, is the independent non-executive chair of Inocucor Technologies.

The announcement coincides with Blome’s speaking engagement at the World Agri-Tech Investment Summit in San Francisco this week.

Inocucor produces biological soil, seed and plant accelerators that improve yields, and promote healthier, more resilient soils and plants for organic farmers, greenhouse growers and mainstream production farmers.

Its first-generation product, Inocucor™ Garden Solution® is approved as a water treatment in Ontario and Quebec and as a soil amendment in 23 U.S. states.

Inocucor was founded in 2007 by two Canadian scientists who combined their knowledge of the human and plant microbiomes to create biological soil and plant accelerators for agriculture.

The company’s patented fermentation process for isolating and combining naturally occurring yeasts and bacteria is similar to that used in winemaking.

 

BBNewsLogo-credit

London, Ontario
By Steve Sabourin on March 4, 2015 8:44am

ABOUT INOCUCOR TECHNOLOGIES INC.

Inocucor Technologies Inc., based in Montreal, is an ag biotech company that develops sustainable biological products for agriculture targeting the phyto-microbiome—the seeds, plants, root systems and the soil surrounding them. Inocucor’s first-generation product, Garden Solution®, soon to be re-branded as Synergro, employs live microbes to actively improve the health of the entire phyto-microbiome. Its second product, Synergro Free and future generations of Inocucor products are powerful biological formulations for bio-stimulation, bio-fertility and bio-control targeting mainstream production agriculture.

For more information, visit www.inocucor.com.

ino_about